Gut microbiota and immunosenescence in cancer
Seminars in Cancer Biology · 2024
DOI: 10.1016/j.semcancer.2024.07.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024. Verfasst von Yaozheng Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110136, China; Liaoning Clinical Research Cente…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Neoplasms, Immunosenescence. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 170 Literaturangaben. Gefördert von: China Medical University, Department of Science and Technology of Liaoning Province.
Abstract (Originalsprache)
Cancer is generally defined as a disease of aging. With aging, the composition, diversity and functional characteristics of the gut microbiota occur changes, with a decline of beneficial commensal microbes triggered by intrinsic and extrinsic factors (e.g., diet, drugs and chronic health conditions). Nowadays, dysbiosis of the gut microbiota is recognized as a hallmark of cancer. At the same time, aging is accompanied by changes in innate and adaptive immunity, known as immunosenescence, as well as chronic low-grade inflammation, known as inflammaging. The elevated cancer incidence and mortality in the elderly are linked with aging-associated alterations in the gut microbiota that elicit systemic metabolic alterations, leading to immune dysregulation with potentially tumorigenic effects. The gut microbiota and immunosenescence might both affect the response to treatment in cancer patients. In-depth understanding of age-associated alterations in the gut microbiota and immunity will shed light on the risk of cancer development and progression in the elderly. Here, we describe the aging-associated changes of the gut microbiota in cancer, and review the evolving understanding of the gut microbiota-targeted intervention strategies. Furthermore, we summarize the knowledge on the cellular and molecular mechanisms of immunosenescence and its impact on cancer. Finally, we discuss the latest knowledge about the relationships between gut microbiota and immunosenescence, with implications for cancer therapy. Intervention strategies targeting the gut microbiota may attenuate inflammaging and rejuvenate immune function to provide antitumor benefits in elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110136, China; Liaoning Clinical Research Center for Laboratory Medicine, Shenyang, Liaoning 110136, China. Electroni…
- Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China. Electronic address: hec@cmu.edu.cn.
Förderung
- China Medical University
- Department of Science and Technology of Liaoning Province
Zitieren
APA
Xu, Y., He, C., Xi, Y., Zhang, Y., & Bai, Y. (2024). Gut microbiota and immunosenescence in cancer. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2024.07.004
Vancouver
Xu Y, He C, Xi Y, Zhang Y, Bai Y. Gut microbiota and immunosenescence in cancer. Seminars in Cancer Biology. 2024. doi:10.1016/j.semcancer.2024.07.004
BibTeX
@article{Xu2024,
author = {Xu, Yaozheng and He, Chuan and Xi, Ying and Zhang, Yue and Bai, Yibo},
title = {Gut microbiota and immunosenescence in cancer},
journal = {Seminars in Cancer Biology},
year = {2024},
doi = {10.1016/j.semcancer.2024.07.004}
}
EUVIMED